Scope of the Study
The global Preclinical Molecular Imaging market is expected to witness high growth in the forecasted period due to technological enhancement, new medical innovations. the significant development in the field of multimodality and optical imaging also helps to boost the global market. The growing demand for preventive care and early diagnosis is proliferating. Hence, several manufacturers in the market are identifying novel methods of disease detection, among which, molecular imaging is currently the most important development. As a functional imaging method molecular imaging aids in the characterization of the physiological events at the cellular and molecular levels.
The market study is being classified by Type (Equipment/Device, Reagents and Imaging Agents and Service) and major geographies with country level break-up.
Siemens AG (Germany), Bruker BioSpin (United States), Toshiba (Japan), Aspect Imaging (Israel), Trifoil Imaging (United States), MILabs (Netherlands), Mediso Medical Imaging Systems (Hungary), Sedecal (Spain), Magnetic Insights, Inc. (United States) and Cubresa (Canada) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Preclinical Molecular Imaging market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Preclinical Molecular Imaging market by Type, Application and Region.
On the basis of geography, the market of Preclinical Molecular Imaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Demand for Multimodality Imaging
- Growing Number of Cardiological Diseases
- Growing Number of Government Initiatives
- The Growing Demand due to Early Detection of Diseases Using Molecular Imaging
- High Cost Associated with Preclinical Molecular Imaging
- High Adoption due to Technological Advancements such as the Emergence of Next Generation of SPECT Cameras Contain Cadmium Zinc Telluride (CZT) Detectors
- Introduction of AI-Enabled Imaging Technology
- Stringent Government Regulation
Market Leaders and their expansionary development strategies
On 28th February 2019, Siemens Healthineers has announced that the new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been installed at the Hospital of the University of Pennsylvania (HUP) in Philadelphia – the first health care institution in the United States to install the technology.
On 1st March 2018, Siemens Healthineers launches Acuson Juniper next-generation ultrasound system. a new ultrasound system with advanced applications and imaging performance while featuring a lightweight, ergonomic design and complete maneuverability for use across a wide variety of clinical segments.
Key Target AudiencePreclinical Molecular Imaging Equipment Manufactures, Preclinical Molecular Imaging Suppliers, Preclinical Molecular Imaging Distributors, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase